Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.3K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.3K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

3.1K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
3.1K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

3.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.8K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

605
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
605
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

393
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
393
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

205
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
205

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise performance in patients with heart failure and impaired iron transport: a single-centre retrospective study.

BMJ open·2026
Same author

Beyond the slope: prognostic utility of the VE/VCO<sub>2</sub> intercept in chronic heart failure.

Open heart·2026
Same author

RoMa: A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy.

Journal of the American Heart Association·2026
Same author

Method Validation of Cardiopulmonary Exercise Testing: Intra- and Inter-Device Comparisons Across Four Metabolic Carts.

European heart journal. Quality of care & clinical outcomes·2026
Same author

When a single ratio illuminates the grey zone: the prognostic value of neutrophil-to-lymphocyte ratio across the cardiovascular spectrum.

European journal of heart failure·2026
Same author

MECKI score thresholds for heart transplantation referral of ambulatory heart failure patients.

ESC heart failure·2026

Related Experiment Video

Updated: Nov 30, 2025

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.3K

Exosomes in Cardiovascular Diseases.

Marta Zarà1, Patrizia Amadio1, Jeness Campodonico2

  • 1Unit of Brain-Heart axis: Cellular and Molecular Mechanisms, Centro Cardiologico Monzino IRCCS, via Parea 4, 20138 Milan, Italy.

Diagnostics (Basel, Switzerland)
|November 17, 2020
PubMed
Summary
This summary is machine-generated.

Exosomes, nano-sized vesicles carrying cellular cargo, show promise as biomarkers for cardiovascular diseases (CVDs). However, standardized methods for exosome isolation and characterization are needed for clinical use.

Keywords:
biomarkerscardiovascular diseasediagnosticexosomesextracellular vesicles

More Related Videos

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
05:30

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

860
Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.0K

Related Experiment Videos

Last Updated: Nov 30, 2025

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.3K
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
05:30

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

860
Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.0K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Biomedical Engineering

Background:

  • Exosomes are nano-sized biovesicles released by most cell types.
  • They contain proteins, lipids, and genetic material, reflecting parental cell status.
  • Exosomes are investigated for their role in cardiovascular diseases (CVDs).

Purpose of the Study:

  • To review the diagnostic and prognostic potential of exosomes in CVDs.
  • To discuss methodologies for exosome isolation, analysis, and characterization.
  • To highlight challenges in clinical translation of exosome-based biomarkers.

Main Methods:

  • Literature review of studies on exosomes in CVDs.
  • Analysis of current methods for exosome isolation and characterization.
  • Discussion of challenges and future directions.

Main Results:

  • Exosomes hold potential as diagnostic and prognostic biomarkers for CVDs due to their cargo and cell-specificity.
  • Evidence for their clinical utility as biomarkers in CVDs is currently limited.
  • Lack of consensus on isolation and characterization methods hinders clinical translation.

Conclusions:

  • Exosomes are promising, but further research and standardization are crucial for their clinical application in CVDs.
  • Standardized protocols for exosome isolation and characterization are essential for reliable biomarker development.
  • The review provides insights into the current state and future prospects of exosome-based diagnostics in cardiovascular medicine.